Why do the COVID-19 mRNA vaccines need to be kept so cold?
Read now →The Pfizer and Moderna vaccine cold chains, explained
I’m a PhD student in Biological Engineering at MIT. Around two billion people in the world are infected with a microscopic bug called Mycobacterium Tuberculosis. Despite this, only a fraction develop tuberculosis. And a fraction of those infected – almost 5,000 a day – die. I put on Stranger Things-esque protection equipment and probe these bacteria to ask, what allows them bacteria to win this tug-of-war? To understand this variation, I look at how both human and bacteria cells change on a genetic level in response to each other, as a member of the Blainey Lab, located in the Broad Institute, and Bryson Lab, located in the Ragon Institute and MIT.
The Pfizer and Moderna vaccine cold chains, explained
They're easier to manufacture than traditional vaccines, but scientifically their history is checkered
Meet the two women recreating mother nature’s baby formula.
Using machine learning tools and viral sequences, researchers are trying to better understand disease transmission
And they're customizable for different types of bodies, gaits, and speeds
Big and small droplets have different physics and even different pathogenic potential
Scientists are buoyed and see a path to future medicines
Engineered viruses may be the key to HIV and tuberculosis vaccines
After a decade of painstaking progress, the underdog is on the brink of treating a broad range of diseases
If your dog has allergies, chances are you do too. Thanks, microbes
'Free-market philanthropy' raises yet more questions about the future of American public research
The most important invention in medicine could save even more lives
From the axolotl's regenerating limbs to naked mole rat cancer resistance, new sequencing is uncovering new possibilities
A microscopic moonshot hopes to revolutionize biology
Researchers increasingly view the disease as a sprawling, evolving metropolis of cells
Researchers have pioneered what may be the most accurate simulation of kidney function to-date
It's complicated, and the road from lab to clinic is long
Prominent researchers can take the gamble, but junior scientists risk retribution
New research finds that we might need to take a step back from the inside of cells
A New York Times story is a case study in what can go wrong in translating science
A new method using paper towels like you have in your kitchen could make diagnosing diseases more affordable
Cells evolved haphazardly, not in one overall arc
A story of failure, collaboration, and incredibly tiny medicine
Even as new therapies raise hopes, diagnoses and costs prevent widespread treatment